Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Annual review of PROTAC degraders as anticancer agents in 2022
Xiao Wang, Zhao-Long Qin, Na Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116166-116166
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 11
Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools for Monitoring Targeted Protein Degradation
Hanfeng Lin, Kristin M. Riching, May Poh Lai, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1367-1375
Open Access | Times Cited: 9
Efficient synthesis of dihydronaphthalenes via cerium-catalyzed annulation of 1-alkoxy substituted 1H-isochromenes with cinnamic acids
Meng Guo, Xuetao Zhang, Wenqi Yang, et al.
Organic & Biomolecular Chemistry (2025)
Closed Access
Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy
Sacha J. Howell, Sacha J. Howell
Advances in experimental medicine and biology (2025), pp. 449-474
Closed Access
Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities
Wen‐Bo Liu, Weiguang Yang, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117314-117314
Closed Access
Synthesis of α-(azidomethyl)glutarimide and its applicationin construction of potential Cereblon ligands <em>via</em> the CuAAC reaction
Liliya R Khuzhakhmetova, Anna Alekseevna Ananeva, Grigory Kantin, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 1, pp. 69-72
Closed Access
Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 4745-4753
Open Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access
Therapeutic targeting of the polyglutamine androgen receptor in Spinal and Bulbar Muscular Atrophy
Agamjot Sangotra, Andrew P. Lieberman
Expert Opinion on Therapeutic Targets (2025), pp. 1-13
Open Access
Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities
Yunhe Liu, Ziyue Wang, Yifei Du, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118109-118109
Closed Access
Discovery of the novel celastrol-based PROTACs for the treatment of non-small cell lung cancer
Chunhui Ma, Fang Wang, Yiqing Wang, et al.
Molecular Diversity (2025)
Closed Access
Rapid and high-throughput screening of proteolysis targeting chimeras using a dual-reporter system expressing fluorescence protein and luciferase
Shuai Meng, Yuan Meng, Xuena Yang, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
A PDE4 shortform degrader: a first in isoform‐specific PDE4 inhibition
Donald H. Maurice
FEBS Journal (2025)
Open Access
Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors
Killian Malosse, Marie Ben Doula, Béatrice Josselin, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 123, pp. 118157-118157
Closed Access
Targeting Oncogenic Pathways: Advances in KRAS, CDK, EGFR, and PROTAC-Based Therapies
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2025)
Closed Access
Vepdegestrant for the treatment of HR+/HER2– breast cancer
Toru Mukohara
Expert Opinion on Pharmacotherapy (2025)
Closed Access
The spindle assembly checkpoint: Molecular mechanisms and kinase-targeted drug discovery
Inês Lima, Fernanda Borges, António Pombinho, et al.
Drug Discovery Today (2025), pp. 104355-104355
Open Access
The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia
Zhuo Qian, Yi‐Ru Bai, Wenjuan Zhou, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108189-108189
Closed Access
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access
Transforming Therapeutic Approaches with PROTAC Technology: New Targets and Potentials
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 573-575
Open Access | Times Cited: 3
Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple Negative Breast Cancer Treatment
Hongye He, Feng Li, Rui Tang, et al.
Biomaterials Research (2024) Vol. 2024
Open Access | Times Cited: 3
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top